HAVRIX

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug HAVRIX contains one active pharmaceutical ingredient (API):

1 Hepatitis A, inactivated vaccine UNII 5BFC8LZ6LQ - HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED)

Inactivated virus of a strain which was originally derived by further serial passage of a proven attenuated strain. The virus is grown, harvested, highly purified, formalin inactivated, and then adsorbed onto amorphous aluminum hydroxyphosphate sulphate. Read about Hepatitis A, inactivated vaccine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07BC02	Hepatitis A, inactivated, whole virus	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BC Hepatitis vaccines
Discover more medicines within J07BC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 510603501159318, 510603502155316
Country: CA	Health Products and Food Branch	Identifier(s): 02187078, 02231056
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 29615-1-02-11
Country: EE	Ravimiamet	Identifier(s): 1020991, 1027000
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 61250, 61396
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 472332, 498691, 585869
Country: FR	Base de données publique des médicaments	Identifier(s): 60152436, 60386414
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 30037, 30039, 30064, 30065
Country: HK	Department of Health Drug Office	Identifier(s): 40826, 42693
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3217, 3572
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1008866, 1014296, 1066762
Country: MT	Medicines Authority	Identifier(s): MA192/02201, MA192/02202, PI1438/02801A
Country: NL	Z-Index G-Standaard	Identifier(s): 14076594, 14138476
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 47961, 62022
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 6720, 6721
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100224297, 100224305
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W13311001, W13311002, W13311003, W57776001, W57776002, W57776003, W57776004, W57776005
Country: SG	Health Sciences Authority	Identifier(s): 08683P, 09728P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 2363031, 7063071
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522967322, 8699522967346
Country: US	FDA, National Drug Code	Identifier(s): 50090-1502, 58160-825, 58160-826
Country: ZA	Health Products Regulatory Authority	Identifier(s): 29/30.1/0310, 31/30.1/0294